Andriy Mushak
CIK: 0002139379
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (0 total)
2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Mushak Andriy
Mushak Andriy (SEC CIK 0002139379) files insider reports with the SEC as Chief Financial Officer of MIRA PHARMACEUTICALS, INC. (MIRA) and Chief Financial Officer of Telomir Pharmaceuticals, Inc. (TELO).
Signal8 holds 2 ownership filings by Mushak Andriy, all Form 3s, filed on Jun 9, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Mushak Andriy's filings is in MIAMI, FL.
Other insiders filing for MIRA PHARMACEUTICALS, INC. (MIRA)
- Whalen Matthew Pratt, Director
- Del Giudice Matthew Paul, Director
- MacPherson Edward Clouston, Director
- Shekhat Denil Nanji, Director
- Aminov Erez, CEO and Chairman
- Weichselbaum Alan, Chief Financial Officer